Interventions for maintenance of surgically induced remission in Crohn’s disease: a systematic review and network meta-analysis

Morris Gordon, Shiyao Liu, Vassiliki Sinopoulou, Daniel Arruda Navarro Albuquerque, Gordon Moran · 2025

Read Interventions for maintenance of surgically induced remission in Crohn’s disease: a systematic review and network meta-analysis by Morris Gordon, Shiyao Liu, Vassiliki Sinopoulou, Daniel Arruda Navarro Albuquerque, Gordon Moran (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12718597.txt.

Description

Morris Gordon and four colleagues compare drugs for holding Crohn's disease quiet after surgery, in a twenty twenty-five review. About half of Crohn's patients need surgery, and many relapse after it. The team pooled thirty-four trials with 3,197 patients in a network analysis. Outcomes were symptom relapse, scope-seen relapse, and quitting from side effects.

One biologic drug, adalimumab, clearly cut symptom relapse against placebo, with fair-grade proof. Two older drug families may cut relapse slightly, on weaker proof. Another biologic probably cut scope-seen relapse. Most other options rested on very weak proof. The authors grade each claim so doctors can weigh certainty, not just effect size.

Catalog record

CREATORMorris Gordon, Shiyao Liu, Vassiliki Sinopoulou, Daniel Arruda Navarro Albuquerque, Gordon Moran
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12718597

Browse the full library · About the Tower of Babel